Finance

Lists
Why is CAMP up 4,17%?
Dive Deeper
CAMP:NASDAQ
CAMP4 Therapeutics Corp
4,00 US$
+4,17%
(+0,16) 1D
4,00 US$
0,00% (0,00)
After hours
Closed: 2 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAMP...
Open
3,90 US$
High
4,05 US$
Low
3,69 US$
Mkt. cap
251,01 მლნ.
Avg. vol.
306,07 ათ.
Volume
367,96 ათ.
52-wk high
7,75 US$
52-wk low
2,86 US$
EPS
-2,20 US$
Shares outstanding
62,75 მლნ.
No. of employees
48
Open
3,90 US$
High
4,05 US$
Low
3,69 US$
Mkt. cap
251,01 მლნ.
Avg. vol.
306,07 ათ.
Volume
367,96 ათ.
52-wk high
7,75 US$
52-wk low
2,86 US$
EPS
-2,20 US$
Shares outstanding
62,75 მლნ.
No. of employees
48
News stories
From web sources and news partners
About CAMP4 Therapeutics Corp
CEO-
Employees48
Founded2015
Headquarters-
Sector-
Websitecamp4tx.com
Analyst ratings
Based on 5 analysts giving stock ratings to CAMP in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CAMP in the last 3 months.
Highest
Current 4,00 US$
15,00 US$ (+275,00%)
Average
9,00 US$ (+125,00%)
Lowest
6,00 US$ (+50,00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yun Zhong
Wedbush
Buy
Maintained
8,00 US$
+100%
09/29/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
15,00 US$
+275%
09/29/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
6,00 US$
+50%
09/29/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
09/29/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
7,00 US$
+75%
09/28/2026
Anupam Rama
J.P. Morgan
Buy
Upgraded
9,00 US$
+125%
06/22/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
7,00 US$
+75%
04/14/2026
Mani Foroohar
Leerink Partners
Buy
Maintained
9,00 US$
+125%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
795,00 ათ.
348,00 ათ.
1,29 მლნ.
1,78 მლნ.
Cost of goods sold
9,36 მლნ.
8,36 მლნ.
10,16 მლნ.
10,82 მლნ.
Cost of revenue
9,36 მლნ.
8,36 მლნ.
10,16 მლნ.
10,82 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,60 მლნ.
4,77 მლნ.
4,20 მლნ.
4,34 მლნ.
Operating expense
4,60 მლნ.
4,77 მლნ.
4,20 მლნ.
4,34 მლნ.
Total operating expenses
13,95 მლნ.
13,12 მლნ.
14,36 მლნ.
15,16 მლნ.
Operating income
-13,16 მლნ.
-12,78 მლნ.
-13,07 მლნ.
-13,38 მლნ.
Other non operating income
-1,87 მლნ.
-28,22 მლნ.
-6,17 მლნ.
-20,96 მლნ.
EBT including unusual items
-15,10 მლნ.
-40,28 მლნ.
-18,33 მლნ.
-33,53 მლნ.
EBT excluding unusual items
-14,60 მლნ.
-40,28 მლნ.
-18,33 მლნ.
-33,53 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15,10 მლნ.
-40,28 მლნ.
-18,33 მლნ.
-33,53 მლნ.
Net profit margin
-1 899,25%
-11 575,86%
-1 416,62%
-1 884,77%
Earnings per share
-0,54
-0,23
-0,21
-0,22
Interest and investment income
423,00 ათ.
716,00 ათ.
910,00 ათ.
807,00 ათ.
Interest expense
-2,00 ათ.
-
-
-
Net interest expenses
421,00 ათ.
716,00 ათ.
910,00 ათ.
807,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-12,74 მლნ.
-12,40 მლნ.
-12,55 მლნ.
-12,86 მლნ.
Gain or loss from assets sale
67,00 ათ.
191,00 ათ.
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები